Abiopharma

🔍 Jisser Ken (Director)

Company: authID Inc. (AUID)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 30,120 shares of Common Stock, $0.0001 par value per share at $1.245 per share (Direct)
  Date: 2026-04-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 122,245.00 | transaction_form_type: 4
• Acquired 250,000 shares of Stock Purchase Warrant at $1.5 per share (Derivative)
  Date: 2026-04-29 | Code: P | Expires: 2031-04-29 | Exercise: 2026-10-29 | equity_swap_involved: 0 | shares_owned_after: 250,000.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 38,024 shares of Stock Options at $3.9 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2035-09-04 | Exercise: 2025-09-04 | shares_owned_after: 38,024.00 | Footnotes: F2
• Holds 15,627 shares of Stock Options at $8.67 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2034-08-13 | Exercise: 2024-08-13 | shares_owned_after: 15,627.00 | Footnotes: F1
• Holds 3,125 shares of Stock Options at $5.48 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2033-06-28 | Exercise: 2023-06-28 | shares_owned_after: 3,125.00
• Holds 12,500 shares of Stock Options at $2.64 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2033-03-14 | Exercise: 2023-03-14 | shares_owned_after: 12,500.00 | Footnotes: F2

Footnotes:

• F1: The shares underlying the stock options vest monthly over a period of 12 months.
• F2: The shares vest annually in equal amounts over a three-year period.
• F3: Acquired on 4/29/2026: 30,120 shares of Common Stock at $1.245 per share and 250,000 warrants to purchase Common Stock (exercise price $1.50, 5-year term, not exercisable until 10/29/2026).